Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup.

@article{Davis2002SuperficialBC,
  title={Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup.},
  author={John W Davis and Seemit I Sheth and Michael J Doviak and Paul F. Schellhammer},
  journal={The Journal of urology},
  year={2002},
  volume={167 2 Pt 1},
  pages={494-500; discussion 501}
}
PURPOSE Intravesical bacillus Calmette-Guerin (BCG) treatment of high risk superficial bladder cancer has reduced recurrence and progression, and lengthened disease specific survival. However, documentation of treatment durability is limited. MATERIALS AND METHODS Between 1981 and 1989, 98 patients with high risk or recurrent transitional cell carcinoma were treated with complete transurethral resection followed by 1 or more 6-week induction courses of BCG, and were followed through 2000. No… CONTINUE READING
35 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

Similar Papers

Loading similar papers…